- Home
- ICLR vs GRAB Comparison
ICLR vs GRAB Comparison
Compare ICLR & GRAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- GRAB
- Stock Information
- Founded
- ICLR 1990
- GRAB 2012
- Country
- ICLR Ireland
- GRAB Singapore
- Employees
- ICLR N/A
- GRAB N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- GRAB Business Services
- Sector
- ICLR Health Care
- GRAB Consumer Discretionary
- Exchange
- ICLR Nasdaq
- GRAB Nasdaq
- Market Cap
- ICLR 16.4B
- GRAB 19.3B
- IPO Year
- ICLR 1998
- GRAB N/A
- Fundamental
- Price
- ICLR $201.39
- GRAB $4.95
- Analyst Decision
- ICLR Strong Buy
- GRAB Buy
- Analyst Count
- ICLR 12
- GRAB 9
- Target Price
- ICLR $278.27
- GRAB $5.84
- AVG Volume (30 Days)
- ICLR 913.3K
- GRAB 44.5M
- Earning Date
- ICLR 02-19-2025
- GRAB 02-19-2025
- Dividend Yield
- ICLR N/A
- GRAB N/A
- EPS Growth
- ICLR 28.78
- GRAB N/A
- EPS
- ICLR 9.53
- GRAB N/A
- Revenue
- ICLR $8,281,675,999.00
- GRAB $2,797,000,000.00
- Revenue This Year
- ICLR $4.00
- GRAB $21.45
- Revenue Next Year
- ICLR $1.37
- GRAB $20.63
- P/E Ratio
- ICLR $21.18
- GRAB N/A
- Revenue Growth
- ICLR 1.99
- GRAB 18.57
- 52 Week Low
- ICLR $181.51
- GRAB $2.98
- 52 Week High
- ICLR $347.72
- GRAB $5.72
- Technical
- Relative Strength Index (RSI)
- ICLR 54.92
- GRAB 53.54
- Support Level
- ICLR $181.51
- GRAB $4.71
- Resistance Level
- ICLR $203.26
- GRAB $5.53
- Average True Range (ATR)
- ICLR 6.32
- GRAB 0.26
- MACD
- ICLR 1.50
- GRAB 0.03
- Stochastic Oscillator
- ICLR 72.45
- GRAB 51.14
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About GRAB Grab Holdings Limited
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore and Malaysia contributed 58% of revenue as of end-2021. Grab's main competitors in Southeast Asia are Foodpanda and Gojek, the ride-sharing arm of GoTo. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.